|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.05 TWD | 0.00% |
|
-1.10% | -18.40% |
Adimmune Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 2,251.62 million compared to TWD 1,793.78 million a year ago. Net income was TWD 290.98 million compared to TWD 43.07 million a year ago.
Basic earnings per share from continuing operations was TWD 0.68 compared to TWD 0.1 a year ago. Diluted earnings per share from continuing operations was TWD 0.68 compared to TWD 0.1 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.40% | 350M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.35B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
ADIMMUNE CORPORATION 
